How many insider declarations has Zoghbi Huda Y filed?

Zoghbi Huda Y has filed 1 public insider declaration with SEC (Form 4).

What is Zoghbi Huda Y's role?

Zoghbi Huda Y's reported role is not specified by the regulator across the filings.

Which companies does Zoghbi Huda Y report trades for?

Zoghbi Huda Y reports trades for Regeneron Pharmaceuticals, INC..

← Executives ★ Sign in to follow

ZH

Zoghbi Huda Y

OFFICERF

·SEC (Form 4)

Regeneron Pharmaceuticals, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Zoghbi Huda Y. Officer active across 1 company, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 1 reports have been recorded. Activity tracked since 10 August 2026. The latest transaction was disclosed on 10 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Zoghbi Huda Y

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Regeneron Pharmaceuticals, INC. (US)

申报1 总计

●

Zoghbi Huda Y

Director高管2026年8月10日Regeneron Pharmaceuticals, INC.

US$640,00017来源 ↗

800 股@ US$800.000.0008% mcap21.6% 占其流量CommonSEC144:0001969223-26-000871

1 条申报中的 1 条

InsidersTradesSigma

← Executives ★ Sign in to follow

ZH

Zoghbi Huda Y

OFFICERF

·SEC (Form 4)

Regeneron Pharmaceuticals, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the complete record of transactions filed by Zoghbi Huda Y. Officer active across 1 company, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 1 reports have been recorded. Activity tracked since 10 August 2026. The latest transaction was disclosed on 10 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.